1997
DOI: 10.1006/expr.1997.4251
|View full text |Cite
|
Sign up to set email alerts
|

Plasmodium falciparum:Evaluation of Lactate Dehydrogenase in Monitoring Therapeutic Responses to Standard Antimalarial Drugs in Nigeria

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
47
1
1

Year Published

2001
2001
2024
2024

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 61 publications
(51 citation statements)
references
References 5 publications
1
47
1
1
Order By: Relevance
“…Cytosolic plasmodial lactate dehydrogenase was monitored as described in Ref. 20 using the MalStat™ assay (Flow, Inc.).…”
Section: Methodsmentioning
confidence: 99%
“…Cytosolic plasmodial lactate dehydrogenase was monitored as described in Ref. 20 using the MalStat™ assay (Flow, Inc.).…”
Section: Methodsmentioning
confidence: 99%
“…pLDHbased RDTs appear to be slightly less sensitive than those detecting HRP2, but the antigen is rapidly cleared from the bloodstream, becoming undetectable at about the same time blood smears become negative after antimalarial therapy. [13][14][15] Thus, if sensitivity is adequate, the increased specificity of pLDH-based assays for acute malaria suggests that they may be better-suited for high-transmission areas, such as much of sub-Saharan Africa. With increasing advocacy for the implementation of RDTs, it is critical that optimal diagnostic strategies are identified.…”
Section: Introductionmentioning
confidence: 99%
“…[27][28][29] However, as with the panmalarial antibody of the ICT Pf/Pv test, the pLDH monoclonal antibodies of the OptiMAL test detect not only asexual parasites, but also gametocytes. 26,30,31 This suggests that in contrast to referral center findings reported to date, and as suggested by a preliminary African study, 30 it is possible that the high rates of posttreatment gametocytemia found after chloroquine or sulfadoxine-pyrimethamine in primary health centers in malaria-endemic areas may lead to gametocyte-associated persistence of pLDH despite clearance of asexual parasites, and as with the ICT Pf/Pv test, it may result in an unreliable ability to predict treatment outcome. 32 Studies of the ability of pLDH clearance to predict treatment outcome in primary health centers in endemic areas are required before pLDH rapid antigen tests can be advocated as prognostic tools in these settings.…”
Section: Discussionmentioning
confidence: 99%